CLINICAL ROLE -
Acute Myocardial Infarction Management Questioned
During the last 4 decades, the epidemiologic characteristics of acute myocardial infarction have changed.
Read More
Shingles Vaccinations Still Lagging
Approximately 1 million Americans develop herpes zoster or shingles every year.
Pharmacists: Be Confident and Ask for What You Want
When you are prepared, focused, and strategic, asking for what you want is easy and gets you closer to your goals.
Ocrevus for Progressive MS: What Pharmacists Need to Know
Ocrevus is the first medication approved for primary-progressive MS. Here's what you should know.
Apixaban Use in Dialysis Patients: A Need to Rethink Dosing?
Apixaban Dosing in Dialysis
Tips for Rocking Your Pharmacy School Orientation
Congratulations on your acceptance into pharmacy school!
Do Chili Peppers Have a Role to Play in Reducing Gut Inflammation?
Active ingredients in chili peppers and cannabis help subside gut inflammation, and could lead to new therapies for diabetes and colitis.
My Spouse Had Shingles: Seeing is Believing
What will it take to increase zoster immunization uptake among our nation's senior population?
Experimental Device Provides Chemotherapy Regulation
An investigational device can detect and regulate drug levels in the blood.
Photoacoustic Microscopy Produces Clearer Picture of Tumor in the Operating Room
Imaging technology highlights cancerous features of a breast tumor.
Kevzara Approval for RA Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
Metformin Shows Promise as Rare Disease Treatment
Metformin may treat Fragile X syndrome.
Neurologic Disorder Treatment May Increase Risk of Opioid Overdose
Pregabalin and gabapentin involved with numerous heroin overdoses.
Sodium Intake May Not Affect Hypertension
High- and low-sodium diets could result in higher blood pressure.
Positive Opinion Issued for Ceritinib in Patients with Lung Cancer
Novartis seeks expanded indication of ceritinib (Zykadia) in the European Union.
Pharmacy Week in Review: May 26, 2017
A look at the top stories in pharmacy last week.
Watch
Phase 3 Biotin Trial Underway for Primary, Secondary Progressive Multiple Sclerosis
Study will assess improvements in mobility and changes in disability in patients with MS.
Vitamin A Could Play a Role in Obesity
Vitamin A and a high-fat diet could lead to a high body mass index.
Gut Microbiome Predicts Biologic Treatment Response in Inflammatory Bowel Disease
Early microbial changes may identify patients most likely to achieve and maintain treatment response.
Oncovirus Latency Mechanisms Discovered
Merkel cell polyomavirus uses protein-mediated mechanisms to remain latent.
Latest Developments in the Search for an HIV Vaccine
Novel strategy prolongs immune system defense against HIV.
Fat Oxidation Inhibitor, Anti-Androgen Therapy Combination Increases Prostate Cancer Sensitivity
Novel combination may improve treatment options for castration resistant prostate cancer.
Incidence of Non-melanoma Skin Cancers Steadily Increasing
New diagnoses of squamous cell carcinoma increased 263% and basal cell carcinoma increased 145%.
Fighting Brain Cancer Through Deletion of Tumor Suppressor Genes
Scientists override tumor growth effects of PTEN deletion.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Marketing Your CPESN Network (and your Pharmacy) to Providers and Payors
The real benefit of an elevator speech is the behind-the-scenes pre-work that was invested to clearly and concisely articulate a brand’s story and the value that it has to a targeted listener.
Living Longer with HIV: Watch for Metabolic Complications
Individuals with HIV are at 1.5-2 times the risk of cardiovascular disease and a disproportionate risk of death.
Pharmacy Patient Satisfaction Highlights SPT Week in Review
Top articles of the week from Specialty Pharmacy Times.
Opioid Agonist Therapy Examined for HIV Prevention
Biosimilar Recommended for FDA Approval Across Multiple Indications
Epoetin alfa biosimilar has indications in cancer, HIV, and chronic kidney disease, among other conditions.